Quantcast

Latest Chronic myelogenous leukemia Stories

2013-10-24 23:03:21

The Cancer Support Community and The Leukemia & Lymphoma Society Partner on a Solution Washington, D.C. (PRWEB) October 24, 2013 The Cancer Support Community's Research and Training Institute and The Leukemia & Lymphoma Society (LLS) have joined forces to launch the Cancer Experience Registry: Chronic Myeloid Leukemia. According to LLS's Facts 2013 booklet, there will be 5,920 new cases of chronic myeloid leukemia (CML) diagnosed in the U.S. this year, making it a rare...

2013-10-08 09:44:05

Two gene alterations pair up to promote the growth of leukemia cells and their escape from anti-cancer drugs, according to a study in The Journal of Experimental Medicine. Chronic myeloid leukemia (CML) is an aggressive cancer of the blood that is often treated with a drug called Imatinib (a.k.a. Gleevec). Although Gleevec is highly effective, some cancer cells can develop resistance to the drug. The mechanism that drives this resistance is not completely understood, but there is evidence...

2013-09-23 23:04:49

Reportbuyer.com just published a new market research report: PharmaPoint: Chronic Myeloid Leukemia (CML) - United Kingdom Drug Forecast and Market Analysis to 2022. London (PRWEB) September 23, 2013 PharmaPoint: Chronic Myeloid Leukemia (CML) - United Kingdom Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, “PharmaPoint: Chronic Myeloid Leukemia (CML) - United Kingdom Drug Forecast and Market Analysis to 2022”. Chronic myeloid leukemia...


Word of the Day
jument
  • A beast of burden; also, a beast in general.
'Jument' ultimately comes from the Latin 'jugum,' yoke.
Related